China Universal Asset Management Company’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-20,216
Closed -$25.5K 512
2025
Q3
$25.5K Sell
20,216
-2,808
-12% -$3.03K ﹤0.01% 456
2025
Q2
$25.8K Buy
23,024
+179
+0.8% +$208 ﹤0.01% 446
2025
Q1
$18.1K Sell
22,845
-1,305
-5% -$1.6K ﹤0.01% 459
2024
Q4
$39.8K Buy
+24,150
New +$60.9K ﹤0.01% 459
2023
Q4
Sell
-2,526
Closed -$5.36K 446
2023
Q3
$5.36K Buy
2,526
+1,236
+96% +$4.09K ﹤0.01% 385
2023
Q2
$6.14K Sell
1,290
-40
-3% -$221 ﹤0.01% 353
2023
Q1
$7.58K Buy
1,330
+343
+35% +$2.07K ﹤0.01% 327
2022
Q4
$9.96K Buy
987
+78
+9% +$1.47K ﹤0.01% 227
2022
Q3
$20K Buy
+909
New +$26.3K 0.01% 156

Other funds holding FATE